Selected Publications

The most up to date list of publications is available at here.

• RAD51 foci in patients with ovarian cancer: association with treatment outcomes

• Transcriptional landscape of 3D vs2D ovarian cancer models

• Description of ovarian cancer patients with brain metastases

• Diagnostic accuracy of liquid biomarkers for the non-invasive diagnosis of endometrial cancer.: a systematic review and meta-analysis

• Differential regulation of genes by the glucogenic hormone asprosin in ovarian cancer

• Preclinical studies on the effect of Rucaparib in ovarian cancer: impact of BRCA2 status

• CTCs and ccfDNA in patients with lung cancer: a comparison between thoracotomy and VATS

• A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer

• Statistical Meta-analysis of risk factors fir endometrial cancer and development of a risk prediction model using artificial neural network algorithm

• Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer

• In Silico and In Vitro Analysis of lncRNA XIST Reveals a Panel of Possible Lung Cancer Regulators and a Five-Gene Diagnostic Signature

• Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients. 

• Perioperative detection of circulating tumour cells in patients with lung cancer 

• Inertia based microfluidic capture and characterisation of circulating tumour cells for the diagnosis of lung cancer

• Role of RAD51AP1 in ovarian and lung cancer

• Prognostic value of the DNA integrity index in patients with malignant tumours

• Effects of rapalogues, resveratrol and dual kinase inhibitors on human ovarian carcinoma cells 

• Human C1Q induces apoptosis in an ovarian cancer cell line via Tumor Necrossis Factor pathway

• Multi-level suppression of Receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for the efficacy against ovarian cancer cells 

• Liquid biopsies in lung cancer: four emerging technologies and potential clinical applications 

• Detection of abundant non-haematopoietic circulating cancer-related cells in patients with advanced epithelial ovarian cancer

• Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

• Kinase Inhibitors and Ovarian Cancer

• Involvement of the Endocrine-Disrupting Chemical Bisphenol A (BPA) in Human Placentation

• Lack of association between Screencell-detected circulating tumour cells and long-term survival of patients undergoing surgery for non-small cell lung cancer: A pilot clinical study.